Codexis, Inc. (CDXS) is a publicly traded Healthcare sector company. As of May 20, 2026, CDXS trades at $2.48 with a market cap of $231.79M and a P/E ratio of -6.99. CDXS moved +2.03% today. Year to date, CDXS is +52.80%; over the trailing twelve months it is +1.23%. Its 52-week range spans $0.96 to $6.08. Analyst consensus is strong buy with an average price target of $6.90. Rallies surfaces CDXS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading CDXS stock inside the company?
Recent CDXS insider activity includes Lutz Stefan sold 5.86K, Lutz Stefan sold 2.49K, Erbez Georgia sold 3.83K, MOORE ALISON sold 3.83K, and Lutz Stefan sold 4.68K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
CDXS Key Metrics
Key financial metrics for CDXS
Metric
Value
Price
$2.48
Market Cap
$231.79M
P/E Ratio
-6.99
EPS
$-0.35
Dividend Yield
0.00%
52-Week High
$6.08
52-Week Low
$0.96
Volume
286.77K
Avg Volume
0
Revenue (TTM)
$78.09M
Net Income
$-31.99M
Gross Margin
88.90%
Recent CDXS Insider Trades
Lutz Stefan sold 5.86K (~$6.64K) on Feb 24, 2026.
Lutz Stefan sold 2.49K (~$3.26K) on Feb 6, 2026.
Erbez Georgia sold 3.83K (~$5.00K) on Feb 6, 2026.
Recent CDXS insider activity includes Lutz Stefan sold 5.86K, Lutz Stefan sold 2.49K, Erbez Georgia sold 3.83K, MOORE ALISON sold 3.83K, and Lutz Stefan sold 4.68K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CDXS?
Yes. Rallies tracks CDXS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CDXS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CDXS. It does not provide personalized investment advice.
